<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        59-186-97
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1997
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RANTAG 300 mg tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        RANITIDINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        300
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        24.2
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Rantag</strong> contains a medicine called ranitidine. This belongs to a group of medicines called H2-receptor antagonists. It lowers the amount of acid in your stomach.</p><p><strong><u>For adults (including the elderly) Rantag is used to: </u></strong></p><p>- Heal and stop ulcers in the stomach, or the part of the gut it empties into (the duodenum)</p><p>- Help clear infections in your stomach, when taken with antibiotic medicines (medicines taken to treat germs)</p><p>- Stop stomach ulcers when they are a side effect of some medicines</p><p>- Stop ulcers from bleeding</p><p>- Improve problems caused by acid in the food pipe (oesophagus) or too much acid in the stomach. Both of these can cause pain or discomfort sometimes known as &lsquo;indigestion&rsquo;, &lsquo;dyspepsia&rsquo; or &lsquo;heartburn&rsquo;</p><p>- Stop acid coming up from the stomach while under anaesthetic during an operation.</p><p><strong><u>For children (3 to 18 years) Rantag is used to: </u></strong></p><p>- Heal ulcers in the stomach, or the part of the gut it empties into (the duodenum)</p><p>- Heal and stop problems caused by acid in the food pipe (oesophagus) or too much acid in the stomach. Both of these can cause pain or discomfort sometimes known as &ldquo;indigestion&rdquo;, &ldquo;dyspepsia&rdquo; or &ldquo;heartburn&rdquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Rantag if: </strong></p><p>- You are allergic to ranitidine or any of the other ingredients of this medicine (listed in Section 6).</p><p>If you are not sure, talk to your doctor or pharmacist before having <strong>Rantag</strong>.</p><p><strong>Warnings and precautions </strong></p><p>Check with your doctor or pharmacist before having your medicine if:</p><p>- You have stomach cancer</p><p>- You have kidney problems. You will need to have a different amount of <strong>Rantag</strong></p><p>- You have had stomach ulcers before and you are taking Non-Steroidal Anti-Inflammatory (NSAID) medicines</p><p>- You have a rare condition called acute porphyria</p><p>- You are over 65 years old</p><p>- You have lung disease</p><p>- You are diabetic</p><p>- You have any problems with your immune system.</p><p>If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before having this medicine.</p><p><strong>Other medicines and Rantag </strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because <strong>Rantag</strong> can affect the way some other medicines work. Also some other medicines can affect the way <strong>Rantag</strong> works.</p><p>In particular tell your doctor or pharmacist if you are taking any of the following medicines:</p><p>- Non-Steroidal Anti-Inflammatory (NSAID) medicines, for pain and inflammation</p><p>- Lidocaine, a local anaesthetic</p><p>- Propranolol, procainamide or n-acetylprocainamide, for heart problems</p><p>- Diazepam, for worry or anxiety problems</p><p>- Phenytoin, for epilepsy</p><p>- Theophylline, for breathing problems (asthma)</p><p>- Warfarin, for thinning your blood</p><p>- Glipizide, for lowering blood glucose</p><p>- Atazanavir or delaviridine, for treating HIV infection</p><p>- Triazolam, for insomnia</p><p>- Gefitnib, for lung cancer</p><p>- Ketoconazole, an anti-fungal medicine, sometimes used for treating thrush.</p><p>Midazolam is a medicine that may be given to you just before you have an operation. Tell the doctor you are taking <strong>Rantag</strong> before your operation in case he or she wants to give you midazolam.</p><p>If you are not sure if any of the above applies to you, talk to your doctor, pharmacist or nurse before having <strong>Rantag</strong>.</p><p><strong>Pregnancy and breast-feeding </strong></p><p>If you are pregnant, might become pregnant or are breast-feeding, you should not take this medicine unless your doctor advises it is essential.</p><p>Ask your doctor, pharmacist or nurse for advice before taking any medicine, if you are pregnant or breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. You should check with your doctor or pharmacist if you are not sure.</p><p><strong>Taking this medicine </strong></p><p>- Take this medicine by mouth.</p><p>- Swallow each tablet whole with a glass of water.</p><p><strong>The usual dose for an adult (including the elderly) is either: </strong></p><p>- 150 mg in the morning and 150 mg in the evening, <strong>or </strong></p><p>- 300 mg at bedtime.</p><p>Your exact dose will depend on your particular stomach condition; your doctor will tell you the dose you should take.</p><p><strong>Children 12 years and over: </strong></p><p>The adult dose is given.</p><p><strong>Children over 30 kg of weight and from 3 to 11 years: </strong></p><p>Your doctor will work out the right dose for you based on your child&rsquo;s weight.</p><p><strong><u>Treatment of stomach or duodenal (small intestine) ulcers: </u></strong></p><p>The usual dose is 2 mg for each kg of body weight, twice a day for four weeks. This dose may be increased to 4 mg for each kg, twice a day. Take each dose about 12 hours apart. The duration of treatment may be increased to 8 weeks.</p><p><strong><u>Treatment of heartburn due to too much acid: </u></strong></p><p>The usual dose is 2.5 mg for each kg of body weight, twice a day for two weeks. This dose may be increased to 5 mg for each kg, twice a day. Take each dose about 12 hours apart.</p><p><strong>If you take more Rantag than you should </strong></p><p><strong>Rantag</strong> is not normally harmful if you take more than you should, unless you take many tablets at once. If this applies to you (or someone else taking this medicine), <strong>you should go to your nearest hospital casualty department straight away. </strong>Take the medicine pack or any remaining medicine with you so that the doctor knows what you have taken.</p><p><strong>If you forget to take Rantag </strong></p><p>- If you forget a dose, take it as soon as you remember it, unless it is nearly time for your next dose.</p><p>- Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you stop taking Rantag </strong></p><p>After a few days of taking the tablets you should start to feel much better. Do not stop taking the tablets without talking to your doctor or pharmacist first, otherwise the original pain and discomfort may come back.</p><p><strong>If you have any further questions on the use of this product, ask your doctor or pharmacist.</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>The following side effects may happen with this medicine.</p><p><strong>Stop taking Rantag and see a doctor straight away, if you notice any of the following serious side effects, you may need urgent medical treatment: </strong></p><p>&middot; Allergic reactions, the signs may include:</p><p>- Rash, itching or hives on the skin &nbsp;</p><p>- Swelling of your face, lips, tongue or other parts of the body</p><p>- Chest pain, shortness of breath, wheezing or having trouble breathing</p><p>- Unexplained fever and feeling faint, especially when standing up</p><p>&middot; Kidney problems, which can lead to back pain, fever, pain when passing urine, blood in the urine and changes in blood tests</p><p>&middot; Severe stomach pain, this may be a sign of something called &lsquo;pancreatitis&rsquo;</p><p>&middot; A slow or irregular heartbeat</p><p>Check with your doctor <strong>at your next visit </strong>if you notice any of the following:</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>- Stomach pain</p><p>- Constipation</p><p>- Feeling sick (nausea)</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>- Skin rash</p><p><strong>Rare side effects that may show up in blood tests: </strong></p><p>- Increase of serum creatinine in the blood (kidney function test)</p><p>- Changes to liver function</p><p>Check with your doctor <strong>as soon as possible </strong>if you notice any of the following:</p><p><strong>Very rare </strong>(may affect up to 1 in 10,000 people)</p><p>- There can be changes in the level of certain substances in your blood. This can lead to you feeling unusually tired or short of breath and being more likely to bruise or get an infection</p><p>- Feeling depressed, confused, seeing or hearing unexplained things (hallucinations)</p><p>- Headache (sometimes severe)</p><p>- Feeling dizzy or having blurred vision</p><p>- Your joints or muscles are painful or swollen or you cannot control their movement</p><p>- Your small blood vessels can become swollen (known as &lsquo;vasculitis&rsquo;). Signs of this can include: a rash, swollen joints or kidney problems</p><p>- Your liver can become swollen. This can lead to: nausea (feeling sick) or vomiting (being sick), loss of appetite or generally feeling unwell, itching, fever, yellowing of the skin and eyes or dark coloured urine</p><p>- Flushing or marks on your skin that look like targets</p><p>- Unexplained hair loss</p><p>- Diarrhoea</p><p>- Impotence</p><p>- Breast tenderness and/or breast enlargement</p><p>- Breast discharge</p><p><strong>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. </strong></p><p><strong><u>To report any side effect(s): </u></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222, <strong>Exts:</strong> 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot; Keep out of the reach and sight of children.</p><p>&middot; Do not use this medicine after the expiry date which is stated on the carton and on the blister.</p><p>&middot; Store below 30&deg;C, in a dry place, protected from light.</p><p>&middot; Medicines should<em> </em>not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is Ranitidine. Each film-coated tablet contains 150mg, or 300mg of Ranitidine (as Hydrochloride).</p><p>The other ingredients: Croscarmellose sodium, microcrystalline cellulose, magnesium stearate, hypromellose, talc and titanium dioxide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Rantag 150mg is available in packs of 10, 20, and 500 tablets.
Rantag 300mg is available in packs of 10 and 500 tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                21/04/2015
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي <strong>رانتاج</strong> على مادة دوائية تعرف باسم رانيتيدين. والتي تنتمي إلى مجموعة من الأدوية تعرف باسم مثبطات مستقبلات الهيستامين من النمط الثاني. حيث تعمل هذه المادة على خفض كمية الحمض في المعدة.</p><p><strong><u>يستخدم رانتاج لدى البالغين (بما في ذلك فئة كبار السن) في:</u></strong></p><p>-&nbsp;&nbsp;&nbsp; الشفاء والوقاية من حدوث قرحات المعدة، أو قرحات الأمعاء (الإثنى عشر)</p><p>-&nbsp;&nbsp;&nbsp; المساعدة على التخلص من حالات العدوى التي تصيب المعدة، عند تناوله بالتزامن مع المضادات الحيوية (الأدوية التي يتم تناولها للقضاء على الجراثيم)</p><p>-&nbsp;&nbsp;&nbsp; للوقاية من حدوث قرحات المعدة عندما يكون حدوث مثل هذه القرحات أحد الآثار الجانبية لبعض الأدوية التي يتناولها المريض.</p><p>-&nbsp;&nbsp;&nbsp; إيقاف نزيف القرحات</p><p>-&nbsp;&nbsp;&nbsp; الشفاء والوقاية من المشاكل الناتجة عن وجود الحمض في المريء أو فرط كمية الحمض في المعدة. حيث أن كلا السببين ينتج عنهم شعور بالألم أو عدم الشعور بالراحة أحياناً يعرف &quot;بعسر الهضم&quot; أو &quot;حرقة المعدة&quot;</p><p>-&nbsp;&nbsp;&nbsp; منع ارتجاع الحمض من المعدة عندما يكون المريض تحت تأثير المخدر أثناء العمليات الجراحية</p><p><strong><u>يستخدم رانتاج لدى الأطفال (بعمر </u></strong><strong><u>3</u></strong><strong><u> </u></strong><strong><u>إلى 18 سنة) في:</u></strong></p><p>-&nbsp;&nbsp;&nbsp; الشفاء والوقاية من حدوث قرحات المعدة، أو قرحات الأمعاء (الإثنى عشر)</p><p>-&nbsp;&nbsp;&nbsp; الشفاء والوقاية من المشاكل الناتجة عن وجود الحمض في المريء أو فرط كمية الحمض في المعدة. حيث أن كلا السببين ينتج عنهم شعور بالألم أو عدم الشعور بالراحة أحياناً يعرف &quot;بعسر الهضم&quot; أو &quot;حرقة المعدة&quot;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>يجب عدم تناول رانتاج في الحالات التالية:</strong></p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه رانيتيدين أو تجاه أياً من المواد الغير فعالة الأخرى التي يحتوي عليها هذا الدواء (المذكورة في البند رقم 6).</p><p>إذا لم تكن متاكداً من ذلك، يرجى منك التحدث مع طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>رانتاج</strong>.</p><p><strong>تحذيرات واحتياطات</strong></p><p>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول هذا الدواء في الحالات التالية:</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من سرطان المعدة</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في الكلى. سوف تكون بحاجة إلى تناول جرعة مختلفة من <strong>رانتاج </strong></p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني مسبقاً من قرحات في المعدة وتتناول أحد أدوية مضادات الالتهاب الغير ستيرويدية</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حالة مرضية نادرة تعرف باسم البورفيريا الحادة</p><p>-&nbsp;&nbsp;&nbsp; إذا كان عمرك يتجاوز 65 عاماً</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من أمراض الرئة</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من داء السكري</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من أية مشاكل في الجهاز المناعي</p><p>يرجي منك التحدث مع طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول الدواء، إذا لم تكن متأكداً من أن أي مما سبق ينطبق عليك.</p><p><strong>تناول الأدوية الأخرى مع رانتاج</strong></p><p>يرجى منك اخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول، تناولت مؤخراً أو قد تتناول أية أدوية أخرى. بما في ذلك الأدوية التي تصرف بدون وصفة طبيبة والأدوية العشبية. حيث أن <strong>رانتاج </strong>قد<strong> </strong>يؤثر<strong> </strong>على آلية عمل بعض الأدوية الأخرى. كما أن &nbsp;بعض الأدوية الأخرى قد تؤثر على آلية عمل <strong>رانتاج</strong>.</p><p>يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه بصورة خاصة إذا كنت تتناول أياً من الأدوية التالية:</p><p>-&nbsp;&nbsp;&nbsp; أدوية مضادات الالتهاب الغير ستيرويدية ، تستخدم لعلاج الألم والالتهاب</p><p>-&nbsp;&nbsp;&nbsp; ليدوكايين، وهو مخدر موضعي</p><p>-&nbsp;&nbsp;&nbsp; بروبرانولول، بروكيناميد أو إن- أسيتيل بروكيناميد، لعلاج مشاكل القلب</p><p>-&nbsp;&nbsp;&nbsp; ديازيبام، لعلاج مشاكل القلق</p><p>-&nbsp;&nbsp;&nbsp; الفينيتوين، لعلاج الصرع</p><p>-&nbsp;&nbsp;&nbsp; ثيوفيلين، لعلاج مشاكل &nbsp;التنفس (الربو)</p><p>-&nbsp;&nbsp;&nbsp; وارفارين، لترقيق الدم</p><p>-&nbsp;&nbsp;&nbsp; جليبيزيد، لتقليل مستوي السكر في الدم</p><p>-&nbsp;&nbsp;&nbsp; أتازانافيرأو ديلافيريدين، لعلاج عدوى نقص المناعة البشرية المكتسبة</p><p>-&nbsp;&nbsp;&nbsp; ترايازولام، لعلاج حالات الأرق</p><p>-&nbsp;&nbsp;&nbsp; جيفتنيب، لعلاج سرطان الرئة</p><p>-&nbsp;&nbsp;&nbsp; كيتوكونازول، وهو دواء مضاد للفطريات، يستخدم أحيانا لعلاج مرض القلاع</p><p>ميدازولام هو دواء قد يعطى لك مباشرة قبل الخضوع للعمليات الجراحية. يرجى منك إخبار طبيبك المعالج بأنك تتناول <strong>رانتاج </strong>قبل الخضوع لإجراء عملية جراحية في حال ما أراد طبيبك المعالج إعطائك ميدازولام.</p><p>إذا لم تكن متاكداً من أي مما ذكر أعلاه ينطبق عليك، تحدث إلى طبيبك المعالج، الصيدلي الذى تتعامل معه أو الممرض قبل&nbsp; تناول <strong>رانتاج</strong>.</p><p><strong>الحمل والرضاعة الطبيعية</strong></p><p>يجب عليك عدم تناول هذا الدواء إذا كنت حاملاً، قد تصبحي حاملاً أو ترضعين طفلك رضاعة طبيعية، ما لم ينصحك طبيبك المعالج بضرورة تناوله.</p><p>إذا كنت حاملاً أو ترضعين طفلك رضاعة طبيعية، يرجى منك استشارة طبيبك المعالج، الصيدلي الذي تتعاملين معه أو الممرض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>احرص دائماً على تناول هذا الدواء بدقة وفقاً لتعليمات طبيبك المعالج أو الصيدلي الذي تتعامل معه. يجب عليك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا لم تكن متأكداً من ذلك.</p><p><strong>تناول هذا الدواء</strong></p><p>-&nbsp;&nbsp;&nbsp; تناول هذا الدواء عن طريق الفم.</p><p>-&nbsp;&nbsp;&nbsp; يجب بلع القرص كاملاً مع كوباً من الماء.</p><p><strong>الجرعه الاعتيادية للبالغون (بما في ذلك فئه كبار السن) إما:</strong></p><p>-&nbsp;&nbsp;&nbsp; 150 ملغم صباحاً و150 ملغم مساءً، <strong>أو</strong></p><p>-&nbsp;&nbsp;&nbsp; 300 ملغم في وقت النوم</p><p>سوف يعتمد مقدار الجرعة الموصوفة لك على حالة المعدة، سوف يخبرك طبيبك المعالج بمقدار الجرعة التي يجب عليك تناولها.</p><p><strong>الأطفال بعمر 12 سنة ومافوق</strong></p><p>يعطى لهم الجرعة الموصى بها للبالغون.</p><p><strong>الأطفال الذين تزيد أوزانهم عن 30 كلغم وتتراوح أعمارهم ما بين 3 إلى 11سنة:</strong></p><p>سوف يعمل طبيبك المعالج على تحديد المقدار الصحيح للجرعة اعتماداً على وزن الطفل</p><p><strong><u>علاج قرحات المعدة والاثنى عشر (الأمعاء الدقيقة):</u></strong></p><p>يبلغ مقدار الجرعة الاعتيادية 2 ملغم لكل كيلوغرام من وزن الجسم، مرتين في اليوم لمدة أربع أسابيع. قد يزداد مقدار الجرعة ليصل إلى 4 ملغم لكل كيلو غرام، مرتين في اليوم. تناول كل جرعة على حدة كل 12 ساعة. قد تزداد مدة العلاج لتصل إلى 8 أسابيع.</p><p><strong><u>علاج حرقة المعدة الناجمةعن فرط كمية حامض المعدة:</u></strong></p><p>يبلغ مقدار الجرعة الاعتيادية 2.5 ملغم لكل كيلوغرام من وزن الجسم، مرتين في اليوم لمدة أسبوعين. قد يزداد مقدار هذه الجرعة ليصل إلى 5 ملغم لكل كيلو غرام، مرتين في اليوم. تناول كل جرعة على حدة كل 12 ساعة.</p><p><strong>إذا تناولت </strong><strong>رانتاج</strong><strong> بجرعة أكبر مما يجب </strong></p><p>عادة لا يسبب <strong>رانتاج </strong>أية أضرار في حال تناولت جرعة بمقدار أكثر مما يجب عليك تناوله، إلا إذا كنت قد تناولت العديد من الأقراص في نفس الوقت. في حال تعرضك لذلك (أو أي شخص آخر يتناول هذا الدواء)، <strong>يجب عليك التوجه على الفور إلى أقرب قسم طوارئ في المستشفى. </strong>كما<strong> </strong>يرجى<strong> </strong>منك<strong> أ</strong>خذ معك عبوة الدواء أو ما تبقى من الدواء لكي يعلم الطبيب المعالج ما هو الدواء الذي قد تناولته.</p><p><strong>إذا سهوت عن تناول رانتاج</strong></p><p>-&nbsp;&nbsp;&nbsp; إذا سهوت عن تناول إحدى الجرعات، يجب عليك تناولها في أسرع وقت ممكن حال تذكرها، إلا إذا كان موعد تناول الجرعة التالية قد اقترب.</p><p>-&nbsp;&nbsp;&nbsp; لا تتناول جرعة مضاعفة لتعويض الجرعة المفردة التي قد سهوت عن تناولها.</p><p><strong>إذا توقفت عن تناول رانتاج</strong></p><p>يجب أن تشعر بعد مرور أيام قليلة من تناول الأقراص بمزيد من التحسن. يجب أن لا تتوقف عن تناول الأقراص من تلقاء نفسك دون استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه أولاً، وإلا سوف يعاودك الشعور بالألم المعتاد وعدم الراحة مرة أخرى.</p><p><strong>إذا كانت لديك مزيد من الاستفسارات التي تخص استعمال هذا الدواء، اتصل بطبيبك أو الصيدلي الذي تتعامل معه. </strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن جميع الأدوية، قد يؤدي هذا الدواء<strong> </strong>إلى حدوث تأثيرات جانبية. على الرغم من ذلك لا يصاب بها كل شخص.</p><p><strong>توقف عن تناول رانتاج واستشر طبيبك المعالج على الفور، إذا لاحظت أي من الأعراض الجانبية الخطيرة التالية، حيث أنك قد تكون بحاجة إلى عناية طبية طارئة:</strong></p><p>&middot; تفاعلات تحسسية، قد تتضمن أعراضها على:</p><p>-&nbsp;&nbsp;&nbsp; طفح جلدي، حكة أو طفح جلدي شبيه بخلايا النحل</p><p>-&nbsp;&nbsp;&nbsp; تورم الوجه، الشفتين، اللسان أو أجزاء أخرى من الجسم</p><p>-&nbsp;&nbsp;&nbsp; ألم بالصدر، ضيق التنفس، أزيز أو مشاكل بالتنفس</p><p>-&nbsp;&nbsp;&nbsp; حمى غير مبررة وشعور بالإغماء، خصوصاً عند الوقوف</p><p>&middot; مشاكل في الكلى، والتي تؤدي إلي ألم الظهر، حمى، ألم أثناء التبول، ظهور دم في البول وتغييرات في اختبارات الدم</p><p>&middot; ألم حاد في المعدة، والذي قد يكون علامة على ما يعرف باسم &quot;بالتهاب البنكرياس&quot;</p><p>&middot; اضطراب نظم ضربات القلب</p><p>يرجى منك استشارة طبيبك المعالج في <strong>الزيارة المقبلة</strong> إذا لاحظت أي من التأثيرات التالية:</p><p><strong>غير شائعة </strong>(تؤثر على ما يصل إلى شخص واحد من كل 100 شخص)</p><p>-&nbsp;&nbsp;&nbsp; ألم في المعدة</p><p>-&nbsp;&nbsp;&nbsp; إمساك</p><p>-&nbsp;&nbsp;&nbsp; الشعور بالإعياء (الغثيان)</p><p><strong>نادرة </strong>(تؤثر على ما يصل إلى شخص واحد من كل 1000 شخص)</p><p>-&nbsp;&nbsp;&nbsp; طفح جلدي</p><p><strong>أعراض جانبية نادرة ممكن أن تظهر في اختبارات الدم:</strong></p><p>-&nbsp;&nbsp;&nbsp; زياده نسبة الكرياتينين في الدم (اختبارات وظائف الكلى<strong>)</strong></p><p>-&nbsp;&nbsp;&nbsp; تغييرات في وظائف الكبد</p><p>يرجى منك استشارة طبيبك المعالج <strong>في أسرع وقت ممكن</strong> إذا لاحظت اياً من الآتي:</p><p><strong>نادرة جداً </strong>(تؤثر على ما يصل إلى شخص واحد من كل 10000 شخص)</p><p>-&nbsp;&nbsp;&nbsp; قد يحدث تغيير في مستوى بعض المواد في الدم. من المحتمل أن يشعرك ذلك الأمر بالتعب على غير المعتاد أو ضيق التنفس وأن تصبح أكثر عرضة لحدوث الكدمات أو الإصابة بالعدوى</p><p>-&nbsp;&nbsp;&nbsp; الشعور بالاكتئاب، الارتباك ورؤية أو سماع أشياء غير مبررة (هلوسة)</p><p>-&nbsp;&nbsp;&nbsp; صداع (شديد في بعض الأحيان)</p><p>-&nbsp;&nbsp;&nbsp; الشعور بالدوار أو عدم وضوح الرؤية</p><p>-&nbsp;&nbsp;&nbsp; &nbsp;ألم أو تورم&nbsp; في المفاصل أو العضلات أو عدم القدرة على السيطرة على حركتهم</p><p>-&nbsp;&nbsp;&nbsp; تورم الأوعية الدموية الصغيرة (المعروف باسم &quot;التهاب الأوعية الدموية&quot;). قد تتضمن أعراض ذلك على: طفح جلدي، تورم المفاصل أو مشاكل في الكلى</p><p>-&nbsp;&nbsp;&nbsp; تورم الكبد مما قد يؤدي إلى: غثيان (الشعور بالإعياء) أو تقيؤ (توعك)، فقدان الشهية أو الشعور بعدم الراحة بصورة عامة، حكة، حمى، اصفرار الجلد والعينين أو بول داكن اللون</p><p>-&nbsp;&nbsp;&nbsp; توهج أو ظهور علامات على الجلد</p><p>-&nbsp;&nbsp;&nbsp; سقوط الشعر الغير مبرر</p><p>-&nbsp;&nbsp;&nbsp; إسهال</p><p>-&nbsp;&nbsp;&nbsp; عجز جنسي</p><p>-&nbsp;&nbsp;&nbsp; ألم بالثدي أوِ/وتضخم الثدي</p><p>-&nbsp;&nbsp;&nbsp; خروج إفرازت من الثدي</p><p><strong>إذا تعرضت لأي تأثير جانبي، يرجى منك التحدث مع طبيبك المعالج، الصيدلي الذي تتعامل معه أوالممرض. هذا يتضمن أي عرض جانبي محتمل حدوثه غير مذكور في هذه النشرة.</strong></p><p><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية</u></strong><strong><u>:</u></strong></p><p><strong>&nbsp;</strong><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong></p><p><strong>رقم الفاكس: </strong>7662-205-11-966+</p><p><strong>يرجى الاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على: </strong>2038222-11-966+<strong>&nbsp;&nbsp; </strong></p><p><strong>وصلة هاتف:</strong>2340-2334-2354-2353-2356-2317</p><p><strong>الهاتف المجاني: 8002490000</strong></p><p><strong>البريد الإلكتروني: </strong>npc.drug@sfda.gov.sa</p><p><strong>الموقع الإلكتروني: </strong>www.sfda.gov.sa/npc</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>-&nbsp;&nbsp;&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p>-&nbsp;&nbsp;&nbsp; لا تتناول هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة أو الشريط.</p><p>-&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30&ordm;م، في مكان جاف وبعيداً عن الضوء.</p><p>-&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي رانيتيدين. يحتوي كل قرص مكسو على 150 ملغم، أو 300 ملغم&nbsp; من رانيتيدين (على هيئة هيدروكلوريد).</p><p>المواد غير الفعالة : كروس كارميلوز الصوديوم، بلورات السليلوز متناهية الصغر، استيارات المغنيسيوم، هيبروميلوز، تلك، وثنائي أكسيد التيتانيوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>يتوفر <strong>رانتاج</strong> 150ملغم في عبوات تحتوي على10، 20، و500 قرصاً.</p><p>يتوفر <strong>رانتاج</strong> 300 ملغم في عبوات تحتوي علي 10و500 قرصاً.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            21/04/2015
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rantag 300mg Film-coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains: 
Item no.	Material Name	Scale (mg/tab)
		
	Active Ingredients:	
1.		Ranitidine	300.000
	Use: Ranitidine HCl *	337.450
		
	Inactive Ingredients:	
2.		Microcrystalline Cellulose (Avicel pH 102)	120.000
3.		Croscarmellose Sodium (Ac-Di-Sol)	10.000
4.		Magnesium Stearate	4.000
		
	Coating Materials	
5.		Hydroxypropyl Methylcellulose (Hypromellose)	9.600
6.		Talc Fine Powder	2.000
7.		Titanium Dioxide	5.260
8.		Ethanol 95% **	q.s.
9.		Purified Water **	q.s.
	
* Used as Ranitidine HCl equivalent to 300mg of Ranitidine compensating the assay and water content of the material.
** Evaporates during manufacturing process and does not appear in the final product.

For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated Tablets
Descriptions: White to off-white, oblong, biconvex film-coated tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Adults</u></strong></p><p><strong>Rantag </strong>tablets are indicated for:</p><p>&sect; Treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents.</p><p>&sect; Treatment of duodenal ulcers associated with&nbsp;<em>Helicobacter pylori&nbsp;</em>infection.</p><p>&sect; Treatment of post-operative ulcer</p><p>&sect; Zollinger-Ellison syndrome</p><p>&sect; Oesophageal reflux disease</p><p>&sect; Chronic episodic dyspepsia, characterised by pain (epigastric or retrosternal) which is related to meals or disturbs sleep but is not associated with the preceding conditions may benefit from ranitidine treatment.</p><p><strong>Rantag</strong> tablets are indicated for the following conditions where reduction of gastric secretion and acid output is desirable:</p><p>&sect; Prophylaxis of gastrointestinal haemorrhage from stress ulceration in seriously ill patients</p><p>&sect; Prophylaxis of recurrent haemorrhage in patients with bleeding peptic ulcers</p><p>&sect; Before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson&#39;s syndrome), particularly obstetric patients during labour.</p><p>For appropriate cases <strong>Rantag</strong> Injection is also available (see separate SPC).</p><p><strong><u>Children (3 to 18 years)</u></strong></p><p>&sect; Short term treatment of peptic ulcer</p><p>&sect; Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Posology</u></strong></p><p><strong><u>Adults (including the elderly)</u></strong></p><p>The usual dosage is 150 mg twice daily, taken in the morning and evening.</p><p>Patients with duodenal ulceration, gastric ulceration or oesophageal reflux disease may be treated with a single bedtime dose of 300 mg. It is not necessary to time the dose in relation to meals.</p><p><strong>Duodenal ulcer, benign gastric ulcer and post-operative ulcer:</strong></p><p>In most cases of duodenal ulcer, benign gastric ulcer and post-operative ulcer, healing occurs in four weeks. Healing usually occurs after a further four weeks of treatment in those patients whose ulcers have not fully healed after the initial course of therapy.</p><p>NSAID associated peptic ulceration, including prophylaxis of duodenal ulcers:</p><p>In ulcers following non-steroidal anti-inflammatory drug therapy or associated with continued non-steroidal anti-inflammatory drugs, eight weeks treatment may be necessary.</p><p>In duodenal ulcer 300 mg twice daily for 4 weeks results in healing rates which are higher than those at 4 weeks with ranitidine 150 mg twice daily or 300 mg nocte. The increased dose has not been associated with an increased incidence of unwanted effects.</p><p><strong>Duodenal ulcers associated with&nbsp;<em>Helicobacter pylori</em>&nbsp;infection:</strong></p><p>For duodenal ulcers associated with&nbsp;<em>Helicobacter pylori</em>&nbsp;infection ranitidine 300 mg at bedtime or 150 mg twice daily may be given with oral amoxicillin 750 mg three times daily and metronidazole 500 mg three times daily for two weeks. Therapy with ranitidine should continue for a further 2 weeks. This dose regimen significantly reduces the frequency of duodenal ulcer recurrence.</p><p>Maintenance treatment at a reduced dosage of 150 mg at bedtime is recommended for patients who have responded to short-term therapy, particularly those with a history of recurrent ulcer.</p><p><strong>Oesophageal reflux disease:</strong></p><p>In the management of oesophageal reflux disease, the recommended course of treatment is either 150 mg twice daily or 300 mg at bedtime for up to 8 weeks or if necessary 12 weeks.</p><p><strong>Zollinger-Ellison syndrome:</strong></p><p>In patients with Zollinger-Ellison syndrome, the starting dose is 150 mg three times daily and this may be increased as necessary. Patients with this syndrome have been given increasing doses up to 6 g per day and these doses have been well tolerated.</p><p><strong>Chronic episodic dyspepsia:</strong></p><p>For patients with chronic episodic dyspepsia the recommended course of treatment is 150 mg twice daily for up to six weeks. Anyone not responding or relapsing shortly afterwards should be investigated.</p><p>In the prophylaxis of haemorrhage from stress ulceration in seriously ill patients or the prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration, treatment with ranitidine tablets 150 mg twice daily may be substituted for ranitidine Injection (see separate SPC) once oral feeding commences in patients considered to be still at risk from these conditions.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Prophylaxis of acid aspiration (Mendleson&#39;s syndrome):</strong></p><p>In patients thought to be at risk of acid aspiration syndrome an oral dose of 150 mg can be given 2 hours before induction of general anaesthesia, and preferably also 150 mg the previous evening.</p><p>In obstetric patients at commencement of labour, an oral dose of 150 mg may be given followed by 150 mg at six hourly intervals. It is recommended that since gastric emptying and drug absorption are delayed during labour, any patient requiring emergency general anaesthesia should be given, in addition, a non-particulate antacid (e.g. sodium citrate) prior to induction of anaesthesia. The usual precautions to avoid acid aspiration should also be taken.</p><p><strong><u>Children 12 years and over</u></strong></p><p>For children 12 years and over the adult dosage is given.</p><p><strong><u>Children from 3 to 11 years and over 30 kg of weight</u></strong></p><p>See section 5.2 Pharmacokinetic properties (Other special populations)</p><p><strong><u>Patients over 50 years of age</u></strong></p><p>See section 5.2 Pharmacokinetic properties (Other special Populations )</p><p><strong><u>Peptic Ulcer Acute Treatment</u></strong></p><p>The recommended oral dose for treatment of peptic ulcer in children is 4 mg/kg/day to 8 mg/kg/day administered as two divided doses to a maximum of 300 mg ranitidine per day for a duration of 4 weeks. For those patients with incomplete healing, another 4 weeks of therapy is indicated, as healing usually occurs after eight weeks of treatment.</p><p><strong><u>Gastro-Oesophageal Reflux</u></strong></p><p>The recommended oral dose for the treatment of gastro-oesophageal reflux in children is 5 mg/kg/day to 10 mg/kg/day administered as two divided doses to a maximum of 600 mg (the maximum dose is likely to apply to heavier children or adolescents with severe symptoms).</p><p><strong><u>Neonates</u></strong></p><p>Safety and efficacy in new-born patients has not been established.</p><p><strong><u>Patients with renal impairment</u></strong></p><p>Accumulation of ranitidine with resulting elevated plasma concentrations will occur in patients with renal impairment (creatinine clearance less than 50 ml/min). Accordingly, it is recommended that the daily dose of ranitidine in such patients should be 150 mg at night for 4-8 weeks. The same dose should be used for maintenance treatment, if necessary. If an ulcer has not healed after treatment, 150 mg twice daily dosage should be instituted followed, if need be, by maintenance treatment of 150 mg at night.</p><p><strong><u>Method of administration</u></strong></p><p>For oral administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Malignancy</u></strong></p><p>The possibility of malignancy should be excluded before commencement of therapy in patients with gastric ulcer and in patients of middle age and over with new or recently changed dyspeptic symptoms) as treatment with ranitidine may mask symptoms of gastric carcinoma.</p><p><strong><u>Renal Disease</u></strong></p><p>Ranitidine is excreted via the kidney and so plasma levels of the drug are increased in patients with renal impairment. The dose should be adjusted as detailed in section 4.2 Patients with renal impairment.</p><p>Regular supervision of patients who are taking non-steroidal anti-inflammatory drugs concomitantly with ranitidine is recommended, especially in the elderly. Current evidence shows that ranitidine protects against NSAID associated ulceration in the duodenum and not in the stomach.</p><p>Rare clinical reports suggest that ranitidine may precipitate acute porphyric attacks. Ranitidine should therefore be avoided in patients with a history of acute porphyria.</p><p>In patients such as the elderly, persons with chronic lung disease, diabetes or the immunocompromised, there may be an increased risk of developing community acquired pneumonia. A large epidemiological study showed an increased risk of developing community acquired pneumonia in current users of ranitidine alone versus those who had stopped treatment, with an observed adjusted relative risk increase of 1.82 (95% CI 1.26-2.64). Post-marketing data indicate reversible mental confusion, depression, and hallucinations have been reported most frequently in severely ill and elderly patients (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ranitidine has the potential to affect the absorption, metabolism or renal excretion of other drugs. The altered pharmacokinetics may necessitate dosage adjustment of the affected drug or discontinuation of treatment</p><p>Interactions occur by several mechanisms including:</p><p><strong>1)&nbsp;&nbsp; </strong><strong>Inhibition of cytochrome P450-linked mixed function oxygenase system: </strong></p><p>Ranitidine at usual therapeutic doses does not potentiate the actions of drugs which are inactivated by this enzyme system such as diazepam, lidocaine, phenytoin, propanolol and theophylline.</p><p>There have been reports of altered prothrombin time with coumarin anticoagulants (e.g. warfarin). Due to the narrow therapeutic index, close monitoring of increased or decreased prothrombin time is recommended during concurrent treatment with ranitidine.</p><p><strong>2)&nbsp;&nbsp; </strong><strong>Competition for renal tubular secretion:</strong></p><p>Since ranitidine is partially eliminated by the cationic system, it may affect the clearance of other drugs eliminated by this route. High doses of ranitidine (e.g. such as those used in the treatment of Zollinger-Ellison syndrome) may reduce the excretion of procainamide and N-acetylprocainamide resulting in increased plasma level of these drugs.</p><p><strong>3)&nbsp;&nbsp; </strong><strong>Alteration of gastric pH:</strong></p><p>The bioavailability of certain drugs may be affected. This can result in either an increase in absorption (e.g. triazolam, midazolam, glipizide) or a decrease in absorption (e.g. ketoconazole, atazanavir, delaviridine, gefitnib).</p><p>There is no evidence of an interaction between ranitidine and amoxicillin or metronidazole.</p><p>If high doses (2 g) of sucralfate are co-administered with ranitidine the absorption of the latter may be reduced. This effect is not seen if sucralfate is taken after an interval of 2 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy</u></strong></p><p>Ranitidine crosses the placenta but therapeutic doses administered to obstetric patients in labour or undergoing caesarean section have been without any adverse effect on labour, delivery or subsequent neonatal progress. Like other drugs, ranitidine should only be used during pregnancy if considered essential.</p><p><strong><u>Breast-feeding</u></strong></p><p>Ranitidine is excreted in human breast milk. Like other drugs, ranitidine should only be used during breast-feeding if considered essential.</p><p><strong><u>Fertility</u></strong></p><p>There are no data on the effects of ranitidine on human fertility. There were no effects on male and female fertility in animal studies (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None reported</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following convention has been utilised for the classification of undesirable effects: very common (&ge;1/10), common (&ge;1/100, &lt;1/10), uncommon (&ge;1/1000, &le;1/100), rare (&ge;1/10,000, &le;1/1000), very rare (&le;1/10,000). Adverse event frequencies have been estimated from spontaneous reports from post-marketing data.</p><table border="0" cellspacing="0" cellpadding="0" style="width:663px"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Blood &amp; Lymphatic System Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Blood count changes (leucopenia, thrombocytopenia). These are usually reversible. Agranulocytosis or pancytopenia, sometimes with marrow hypoplasia or marrow aplasia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune System Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Hypersensitivity reactions (urticaria, angioneurotic oedema, fever, bronchospasm, hypotension and chest pain).</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Anaphylactic shock.</p></td></tr><tr><td style="vertical-align:top"><p>Not known:</p></td><td style="vertical-align:top"><p>Dyspnoea.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>These events have been reported after a single dose.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Psychiatric Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Reversible mental confusion, depression and hallucinations.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>These have been reported predominantly in severely ill patients, in elderly and in nephropatic patients.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Nervous System Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Headache (sometimes severe), dizziness. and reversible involuntary movement disorders.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Eye Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Reversible blurred vision.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>There have been reports of blurred vision, which is suggestive of a change in accommodation.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Cardiac Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>As with other H<sub>2</sub>&nbsp;receptor antagonists bradycardia, A-V block and tachycardia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Vascular Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Vasculitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Abdominal pain, constipation, nausea (these symptoms mostly improved during continued treatment).</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Acute pancreatitis, diarrhoea</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Transient and reversible changes in liver function tests.</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Hepatitis (hepatocellular, hepatocanalicular or mixed) with or without jaundice, these were usually reversible.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin and Subcutaneous Tissue Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Skin Rash.</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Erythema multiforme, alopecia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Musculoskeletal and Connective Tissue Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Musculoskeletal symptoms such as arthralgia and myalgia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Renal and Urinary Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Elevation of plasma creatinine (usually slight; normalised during continued treatment)</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Acute interstitial nephritis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Reproductive System and Breast Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Reversible impotence, breast symptoms and breast conditions (such as gynaecomastia and galactorrhoea).</p></td></tr></tbody></table><p><strong>Paediatric population</strong></p><p>The safety of ranitidine has been assessed in children ages 0 to 16 years with acid-related disease and was generally well tolerated with an adverse event profile resembling that in adults. There are limited long term data available, in particular regarding growth and development.</p><p>&nbsp;</p><p><strong><em><u>To report any side effect(s)</u></em></strong><strong><em><u>:</u></em></strong><strong><em><u> </u></em></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222, <strong>Exts:</strong> 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Symptoms and signs</u></strong></p><p>Ranitidine is very specific in action and accordingly no particular problems are expected following overdosage.</p><p><strong><u>Treatment</u></strong></p><p>Symptomatic and supportive therapy should be given as appropriate.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong> H2-receptor antagonists</p><p><strong>ATC code:</strong> A02BA02</p><p><strong><u>Mechanism of action</u></strong></p><p>Ranitidine is a specific rapidly acting histamine H<sub>2</sub>-antagonist. It inhibits basal and stimulated secretion of gastric acid, reducing both the volume and the acid and pepsin content of the secretion. Ranitidine has a relatively long duration of action and so a single 150 mg dose effectively suppresses gastric acid secretion for twelve hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Absorption</u></strong></p><p>Following oral administration of 150 mg ranitidine, maximum plasma concentrations (300 to 550 ng/mL) occurred after 1&mdash;3 hours. Two distinct peaks or plateau in the absorption phase result from reabsorption of drug excreted into the intestine. The absolute bioavailability of ranitidine is 50-60% and plasma concentrations increase proportionally with increasing dose up to 300 mg.</p><p><strong><u>Distribution</u></strong></p><p>Ranitidine is not extensively bound to plasma proteins (15%), but exhibits a large volume of distribution ranging from 96 to 142 L.</p><p><strong><u>Metabolism</u></strong></p><p>Ranitidine is not extensively metabolised. The fraction of the dose recovered as metabolites is similar after both oral and i.v. dosing; and includes 6% of the dose in urine as the N-oxide, 2% as the S-oxide, 2% as desmethylranitidine and 1 to 2% as the furoic acid analogue.</p><p><strong><u>Elimination</u></strong></p><p>Plasma concentrations decline bi-exponentially, with a terminal half-life of 2-3 hours. The major route of elimination is renal. After IV administration of 150 mg 3H-ranitidine, 98% of the dose was recovered, including 5% in faeces and 93% in urine, of which 70% was unchanged parent drug. After oral administration of 150 mg 3H-ranitidine, 96% of the dose was recovered, 26% in faeces and 70% in urine of which 35% was unchanged parent drug. Less than 3% of the dose is excreted in bile. Renal clearance is approximately 500 mL/min, which exceeds glomerular filtration indicating net renal tubular secretion.</p><p><strong><u>Other special populations</u></strong></p><p><strong><u>Children (3 years and above)</u></strong></p><p>Limited pharmacokinetic data have shown that there are no significant differences in half-life (range for children 3 years and above: 1.7 - 2.2 h) and plasma clearance (range for children 3 years and above: 9 - 22 ml/min/kg) between children and healthy adults receiving oral ranitidine when correction is made for body weight.</p><p><strong><u>Patients over 50 years of age</u></strong></p><p>In patients over 50 years of age, half-life is prolonged (3-4 h) and clearance is reduced, consistent with the age-related decline of renal function. However, systemic exposure and accumulation are 50% higher. This difference exceeds the effect of declining renal function, and indicates increased bioavailability in older patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated-dose toxicity, genotoxicity, carcinogenic potential and toxicity to reproduction and development.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" align="left" style="width:669px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Inactive Ingredients:</u></strong></p></td></tr><tr><td><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Microcrystalline Cellulose (Avicel pH 102)</p></td></tr><tr><td><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Croscarmellose Sodium (Ac-Di-Sol)</p></td></tr><tr><td><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Magnesium Stearate</p></td></tr><tr><td><p>&nbsp;</p></td></tr><tr><td><p><strong><u>Coating Materials</u></strong></p></td></tr><tr><td><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hydroxypropyl Methylcellulose (Hypromellose)</p></td></tr><tr><td><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Talc Fine Powder</p></td></tr><tr><td><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Titanium Dioxide</p></td></tr><tr><td><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ethanol 95% **</p></td></tr><tr><td><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purified Water **</p></td></tr></tbody></table><p>&nbsp;</p><p>** Evaporates during manufacturing process and does not appear in the final product.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months from the date of manufacturing.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30<sup>o</sup>C, in a dry place, protected from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&sect; 10 tablets in aluminum foil strip, in a printed carton along with a leaflet.</p><p>&sect; 10 tablets in aluminum foil strip, 50 strips in a printed carton along with a leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special instructions. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street
Ras Al Khaimah - United Arab Emirates
P.O. Box 997
Tel. No.:   (9717) 2 461 461
Fax No.:   (9717) 2 462 462


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                26. June. 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>